1. Home
  2. MDGL vs NXST Comparison

MDGL vs NXST Comparison

Compare MDGL & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • NXST
  • Stock Information
  • Founded
  • MDGL 2011
  • NXST 1996
  • Country
  • MDGL United States
  • NXST United States
  • Employees
  • MDGL N/A
  • NXST N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • NXST Broadcasting
  • Sector
  • MDGL Health Care
  • NXST Industrials
  • Exchange
  • MDGL Nasdaq
  • NXST Nasdaq
  • Market Cap
  • MDGL 6.1B
  • NXST 5.2B
  • IPO Year
  • MDGL N/A
  • NXST 2003
  • Fundamental
  • Price
  • MDGL $314.31
  • NXST $180.02
  • Analyst Decision
  • MDGL Strong Buy
  • NXST Strong Buy
  • Analyst Count
  • MDGL 9
  • NXST 7
  • Target Price
  • MDGL $420.63
  • NXST $206.43
  • AVG Volume (30 Days)
  • MDGL 282.4K
  • NXST 298.7K
  • Earning Date
  • MDGL 08-06-2025
  • NXST 08-07-2025
  • Dividend Yield
  • MDGL N/A
  • NXST 4.12%
  • EPS Growth
  • MDGL N/A
  • NXST 68.15
  • EPS
  • MDGL N/A
  • NXST 19.70
  • Revenue
  • MDGL $317,383,000.00
  • NXST $5,357,000,000.00
  • Revenue This Year
  • MDGL $286.17
  • NXST N/A
  • Revenue Next Year
  • MDGL $64.17
  • NXST $10.32
  • P/E Ratio
  • MDGL N/A
  • NXST $9.17
  • Revenue Growth
  • MDGL N/A
  • NXST 8.00
  • 52 Week Low
  • MDGL $200.63
  • NXST $141.66
  • 52 Week High
  • MDGL $377.46
  • NXST $191.86
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 64.53
  • NXST 56.92
  • Support Level
  • MDGL $284.02
  • NXST $176.63
  • Resistance Level
  • MDGL $311.21
  • NXST $186.41
  • Average True Range (ATR)
  • MDGL 11.94
  • NXST 4.79
  • MACD
  • MDGL 2.74
  • NXST 0.69
  • Stochastic Oscillator
  • MDGL 100.00
  • NXST 65.70

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. The 2019 merger with Tribune made Nexstar the top broadcast affiliate for both Fox and CBS as well as the number two partner for NBC and number three for ABC. The firm maintains stations in 13 of the top 20 television markets and reaches 68% of US TV households. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

Share on Social Networks: